MENU

Eureka projects

Generation & optimization of anti-FCGR2B antibodies to create tolerizing vaccines for autoimmune diseases and severe allergy
Cut-off: 
3
Ranking: 
16
Project ID: 
5307

Proof of Concept study for the development of a biosimilar monoclonal antibody using the Quality by Design (QbD) approach.
Cut-off: 
4
Ranking: 
7
Project ID: 
5690

REAL TIME AND 3D NAVIGATION SYSTEM FOR SENTINEL NODE DETECTION AND PRECISE LOCALIZATION IN THE OPERATING ROOM
Cut-off: 
6
Ranking: 
45
Project ID: 
6560

Alginate derived oligosaccharide G-block as a new drug candidate in the treatment of cystic fibrosis.
Cut-off: 
6
Ranking: 
27
Project ID: 
6628

Development of a technology platform for the discovery of new industrial biocatalysts from marine bacterial diversity.
Cut-off: 
7
Ranking: 
39
Project ID: 
6801

Portable Aptamer Biosensors for the Detection of Pathogens On-the-Spot (Legionella/Amoeba Complex)
Cut-off: 
7
Ranking: 
12
Project ID: 
6994

Development of Foxy-5 as a first in class anti-metastatic cancer drug
Cut-off: 
7
Ranking: 
19
Project ID: 
7090

Development of new dyslexia diagnosis, monitoring and reeducation tools in the framework of a European comparative study
Cut-off: 
8
Ranking: 
52
Project ID: 
7378

PONS: Patient-Derived Neurons as a Novel Test System for Schizophrenia Drug Development
Cut-off: 
9
Ranking: 
21
Project ID: 
7675

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.